SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARALDI, Pier Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.687
AS - Asia 16.832
EU - Europa 11.636
SA - Sud America 2.739
AF - Africa 324
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 30
Totale 69.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.077
SG - Singapore 6.307
CN - Cina 5.298
DE - Germania 3.370
UA - Ucraina 2.313
BR - Brasile 2.307
TR - Turchia 1.771
HK - Hong Kong 1.539
GB - Regno Unito 1.292
IT - Italia 1.075
RU - Federazione Russa 873
VN - Vietnam 867
SE - Svezia 865
FI - Finlandia 705
FR - Francia 323
MX - Messico 304
CA - Canada 260
PL - Polonia 242
IN - India 237
AR - Argentina 174
ZA - Sudafrica 163
JP - Giappone 143
NL - Olanda 119
BD - Bangladesh 110
BE - Belgio 98
ES - Italia 87
ID - Indonesia 83
IQ - Iraq 73
MA - Marocco 57
EC - Ecuador 52
CO - Colombia 48
LT - Lituania 48
CZ - Repubblica Ceca 45
KR - Corea 44
CL - Cile 43
PK - Pakistan 43
PY - Paraguay 42
TW - Taiwan 35
UZ - Uzbekistan 34
AT - Austria 33
AE - Emirati Arabi Uniti 30
EG - Egitto 29
IL - Israele 28
IR - Iran 28
SA - Arabia Saudita 28
AU - Australia 26
VE - Venezuela 26
EU - Europa 24
KE - Kenya 23
UY - Uruguay 21
NP - Nepal 18
JO - Giordania 17
PE - Perù 16
TN - Tunisia 15
CH - Svizzera 14
MY - Malesia 14
GR - Grecia 13
RO - Romania 13
IE - Irlanda 12
AZ - Azerbaigian 11
BG - Bulgaria 11
DZ - Algeria 11
PT - Portogallo 11
KZ - Kazakistan 10
HU - Ungheria 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
KG - Kirghizistan 8
LV - Lettonia 8
MD - Moldavia 8
PS - Palestinian Territory 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
AL - Albania 7
OM - Oman 7
BH - Bahrain 6
BO - Bolivia 6
PA - Panama 6
PH - Filippine 6
DO - Repubblica Dominicana 5
HN - Honduras 5
HR - Croazia 5
RS - Serbia 5
AO - Angola 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GY - Guiana 4
LB - Libano 4
MK - Macedonia 4
NI - Nicaragua 4
SN - Senegal 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BY - Bielorussia 3
DK - Danimarca 3
GA - Gabon 3
GT - Guatemala 3
MT - Malta 3
SV - El Salvador 3
Totale 69.241
Salva come PNG Salva come JPEG
Città #
Singapore 3.799
Woodbridge 3.789
Fairfield 3.579
Ashburn 3.233
Dallas 2.737
Houston 2.476
Jacksonville 2.448
Chandler 2.073
Ann Arbor 1.911
Seattle 1.523
Hong Kong 1.516
Santa Clara 1.479
Beijing 1.450
Wilmington 1.377
Cambridge 1.092
Izmir 800
Nanjing 774
Princeton 511
Los Angeles 462
Boardman 400
New York 370
Munich 367
San Diego 321
Ferrara 270
Ho Chi Minh City 268
Shenyang 263
Milan 227
Hefei 219
Shanghai 217
Nanchang 213
São Paulo 213
Warsaw 195
Mexico City 187
Tianjin 178
London 160
Hanoi 159
Hebei 157
Falkenstein 154
San Mateo 153
Changsha 148
Bremen 144
Addison 141
Chicago 128
Helsinki 122
Jiaxing 121
Tokyo 116
Dearborn 114
Dong Ket 114
Turku 112
Jinan 111
Brooklyn 109
Brussels 97
The Dalles 93
Philadelphia 92
Montreal 87
Orem 87
Falls Church 86
Norwalk 84
Moscow 83
Frankfurt am Main 82
Kunming 79
Redwood City 78
Johannesburg 75
Zhengzhou 75
Rio de Janeiro 73
San Francisco 71
Amsterdam 70
Atlanta 70
Chennai 70
Denver 62
Toronto 62
Stockholm 61
Guangzhou 60
Mountain View 59
Phoenix 58
Poplar 58
Boston 57
Buffalo 57
Ningbo 51
Brasília 50
Belo Horizonte 49
Auburn Hills 47
Orange 47
Manchester 46
San Jose 46
Verona 43
Des Moines 42
Jakarta 40
Indiana 37
Hangzhou 36
Taizhou 36
Ankara 35
Curitiba 35
Haiphong 35
Da Nang 34
Council Bluffs 33
Lanzhou 32
Mumbai 32
Dhaka 30
Paris 30
Totale 46.052
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.175
1,4-Diketones via Isoxazole Intermediates 1.170
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 1.129
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 488
A glance at adenosine receptors: Novel target for antitumor therapy 267
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 262
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 261
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 252
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 249
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 242
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 241
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 240
3,5-Disubstituted isoxazoles as a latent aldol moiety: Application to the synthesis of (±)-[6]-gingerol 238
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 238
A3 adenosine receptor antagonists: History and future perspectives 236
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 234
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 234
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 234
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 231
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 228
The use of phase-transfer catalysis for the N-alkylation of indole. 228
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 227
null 227
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 227
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 226
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 223
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 222
Allosteric modulators for the A1-adenosine receptor 220
The A3 adenosine receptor: history and perspectives 219
Adenosine receptors and human melanoma 218
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 217
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 216
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 215
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 212
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 211
DNA minor groove binders as potential antitumor and antimicrobial agents 211
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 210
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 209
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 209
Allosteric enhancers for A(1) adenosine receptor 207
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 206
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 206
3,5-Disubstituted Isoxazoles as Synthons for (±)-Pyrenophorin and (±)-Vermiculine Synthesis 205
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 205
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 204
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 204
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 201
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 200
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 199
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 199
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization 199
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 199
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 199
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 198
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 197
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 196
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 196
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 195
A new simple synthesis of a-substituted acrylonitriles 194
Hybrid molecules between distamycin A and active moieties of antitumor agents 194
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 193
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 193
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 192
Hybrid molecules based on distamycin A as potential antitumor agents 192
A one-pot glycosylation of tetrahydropyranyl (THP) ether intermediates 191
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 191
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 191
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 191
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 191
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 190
Current status of A1 adenosine receptor allosteric enhancers 189
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 188
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 188
Carboxyl activation in peptide synthesis using 4-oximino-pyrazol-5-ones 188
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 188
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 187
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 186
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 185
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 185
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 185
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 185
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 184
A mild one-pot synthesis of thieno[3,4-c]pyrazoles and their conversion into pyrazole analogs of o-quinodimethane 184
Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents 184
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 183
A new synthetic approach to indazole synthesis 183
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 182
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 182
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 182
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles 182
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 182
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 180
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 180
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 180
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 179
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 178
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 177
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 177
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 177
Totale 23.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.013
Totale 302.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.814 0 0 0 0 0 648 146 726 122 784 835 553
2021/20225.094 159 470 372 291 373 250 208 243 197 361 528 1.642
2022/20234.800 508 249 108 646 881 773 145 390 611 31 286 172
2023/20242.411 243 307 129 82 170 287 95 394 28 60 56 560
2024/20259.331 291 294 752 335 1.154 770 273 638 1.285 1.084 1.377 1.078
2025/202617.146 2.653 1.709 4.045 3.576 3.659 1.504 0 0 0 0 0 0
Totale 69.762